Showing results (11-20 of 28) with videos related to

Sort By:
Pageof 3
Gynecologic Oncology|April 3, 2025
Consolidation courses in low-risk gestational trophoblastic neoplasia and relapse rate: A MITO-9 retrospective studyRaffaella Cioffi, Robert Fruscio, Giulia Sabetta, et al.
European Journal of Cancer (Oxford, England : 1990)|August 3, 2010
Paclitaxel/carboplatin versus topotecan/paclitaxel/carboplatin in patients with FIGO suboptimally resected stage III-IV epithelial ovarian cancer a multicenter, randomized studyGiorgio Bolis, Giovanna Scarfone, Francesco Raspagliesi, et al.
Clinical Breast Cancer|November 26, 2013
Metformin decreases circulating androgen and estrogen levels in nondiabetic women with breast cancerCarlo Campagnoli, Franco Berrino, Elisabetta Venturelli, et al.
In Vivo (Athens, Greece)|October 31, 2019
Axillary Dissection <i>vs</i>. no Axillary Dissection in Breast Cancer Patients With Positive Sentinel Lymph Node: A Single Institution ExperienceRiccardo Arisio, Fulvio Borella, Mauro Porpiglia, et al.
Gynecologic Oncology|September 30, 2018
Does methotrexate (MTX) dosing in a 8-day MTX/FA regimen for the treatment of low-risk gestational trophoblastic neoplasia affect outcomes? The MITO-9 studyGiorgia Mangili, Raffaella Cioffi, Saverio Danese, et al.
The Oncologist|April 15, 2006
Outcome of patients with HER2-positive advanced breast cancer progressing during trastuzumab-based therapyFilippo Montemurro, Michela Donadio, Matteo Clavarezza, et al.
Clinical Breast Cancer|May 22, 2012
Effect of different doses of metformin on serum testosterone and insulin in non-diabetic women with breast cancer: a randomized studyCarlo Campagnoli, Patrizia Pasanisi, Chiara Abbà, et al.
Gynecologic Oncology|December 17, 2023
Reproductive outcomes after conservative treatment in early and advanced stage MOGCTsFrancesca M Vasta, Gennaro Cormio, Chiara Cassani, et al.
European Journal of Cancer (Oxford, England : 1990)|January 22, 2005
Combination regimen of epirubicin, vinorelbine and 5-fluorouracil continuous infusion as first-line chemotherapy in anthracycline-naive metastatic breast cancer patientsAlfredo Berruti, Raffaella Bitossi, Alberto Bottini, et al.
Breast Cancer Research and Treatment|December 15, 2015
5-Fluorouracil, epirubicin and cyclophosphamide versus epirubicin and paclitaxel in node-positive early breast cancer: a phase-III randomized GONO-MIG5 trialLucia Del Mastro, Alessia Levaggi, Andrea Michelotti, et al.
Pageof 3